Dartford and Gravesham NHS Trust has introduced a new approach to caring for patients who carry MRSA. It aims to reduce delays before surgery, support patient safety and help make the best use of operating theatre time.
MRSA is a type of bacteria. Some people carry it without feeling unwell, but it can cause infections, particularly after an operation. Treating patients before surgery helps reduce this risk.
As part of the new approach, eligible patients having planned orthopaedic surgery at Queen Mary's Hospital can receive a five-minute nasal treatment called Steriwave. This offers an alternative to the traditional five-day treatment programme. Patients can be assessed and treated within 24 hours.
This quicker approach gives teams more flexibility when planning operations, especially when arrangements change at short notice. It can help avoid unnecessary delays for patients and make better use of available theatre time.
The Trust has also developed clear pathways for patients having planned surgery, those admitted as emergencies and patients already in hospital.
The changes have been developed through joint working between the Infection Prevention and Control team and clinical and operational colleagues across DGT.
